Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs13430346 | chr2:47166822 | C/T | 3.11E-6 | 491 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs1358299 | chr2:178767800 | T/C | 3.83E-5 | 494 | 30.33 | 35.33 | 20.48 | KM Plot |
| PRAD | rs1358592 | chr4:74373849 | C/T | 9.26E-7 | 494 | 26.48 | 30.8 | 31.4 | KM Plot |
| PRAD | rs137931694 | chr12:10726775 | C/CT | 5.27E-5 | 490 | 30.77 | 32.9 | 19.93 | KM Plot |
| PRAD | rs137983876 | chr17:79628565 | G/C | 3.42E-7 | 485 | 30.47 | 32.83 | 24.67 | KM Plot |
| PRAD | rs138145253 | chr1:93727931 | AAAC/A | 3.77E-6 | 492 | 31.37 | 26.8 | 18.97 | KM Plot |
| PRAD | rs138180324 | chr1:1127608 | G/GT | 1.43E-5 | 484 | 31.3 | 29.1 | 24.75 | KM Plot |
| PRAD | rs138211113 | chr3:133456148 | A/G | 5.67E-5 | 492 | 30.9 | 30.93 | 35.33 | KM Plot |
| PRAD | rs138436990 | chr7:6723575 | CTT/C | 3.47E-7 | 490 | 31.18 | 26.7 | 50.03 | KM Plot |
| PRAD | rs138526574 | chr9:72894594 | G/A | 1.8E-5 | 491 | 30.93 | 31.35 | 22.45 | KM Plot |
| PRAD | rs138693236 | chr19:45452857 | CTCTTT/C | 1.14E-5 | 487 | 30.3 | 31 | 45.2 | KM Plot |
| PRAD | rs138748233 | chr15:83362809 | G/A | 4.13E-7 | 492 | 31.07 | 31.02 | 29.08 | KM Plot |
| PRAD | rs138775179 | chr5:7314085 | CAG/C | 1.47E-8 | 481 | 30.8 | 31.12 | 10.07 | KM Plot |
| PRAD | rs138976460 | chr1:202697911 | AAC/A | 7.79E-6 | 485 | 31.07 | 29.17 | 37.17 | KM Plot |
| PRAD | rs138992297 | chr5:154304418 | G/A | 0 | 488 | 30.3 | 32.4 | 4.87 | KM Plot |